Rationale And Objectives: Although endocardial ejection indexes lead to overestimation of contractility in hypertrophied hearts, circumferential fiber shortening at the mid wall (cFS) is less affected by wall thickness. In this study magnetic resonance tagging is exploited to assess directly cFS in normal and hypertrophied hearts.
Methods: A novel tagging procedure generates freely definable, convex ring saturation bands. Data acquisition during the cardiac cycle is achieved with a fast, single breath-hold echo-planar imaging measurement that is combined with a slice-following approach and a navigator-guided breath-holding technique to improve reproducibility of breath hold positions.
Results: The procedure is able to create variably shaped convex saturation structures on the myocardium that can be tracked automatically throughout the cardiac cycle. Circumferential shortening at the endocardial border (FSendo) obtained in 6 healthy volunteers and in 6 patients with hypertensive cardiomyopathy suggested hypercontractility of hypertrophied hearts (30.7 +/- 4.1% vs. 43.9 +/- 4.4% respectively; P < 0.002), whereas shortening at the level of the myofibers assessed as cFS was not different (17.2 +/- 1.4% vs. 18.1 +/- 2.8% respectively; P = 0.49).
Conclusions: The presented approach allows for assessment of midwall myocardial mechanics and may become a useful tool to study contractile function in hypertrophied hearts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.rli.0000084888.79706.3a | DOI Listing |
Turk Kardiyol Dern Ars
January 2025
Department of Cardiology, Istanbul Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Türkiye.
Objective: Although left ventricular hypertrophy frequently accompanies end-stage renal disease, heart failure (HF) with reduced ejection fraction (EF) is also observed in a subset of patients. In those patients kidney transplantation (KT) is generally avoided due to an increased risk of mortality in addition to the risks associated with HF. This prospective study was designed to follow patients with HF who were being prepared for KT.
View Article and Find Full Text PDFChronic exposure to high altitudes causes pathophysiological cardiac changes that are characterized by cardiac dysfunction, cardiac hypertrophy, and decreased energy reserves. However, finding specific pharmacological interventions for these pathophysiological changes is challenging. In this study, we identified tetramethylpyrazine (TMP) as a promising drug candidate for cardiac dysfunction caused by simulated high-altitude exposure.
View Article and Find Full Text PDFDiagnostics (Basel)
January 2025
Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus.
Hypertension is a major risk factor of various cardiac complications, including hypertensive heart disease (HHD). This condition can lead to a number of structural and functional changes in the heart, such as left ventricular hypertrophy, diastolic dysfunction, and, eventually, systolic dysfunction. In the management of hypertensive heart disease, early diagnosis and appropriate treatment are crucial for preventing the progression to congestive heart failure.
View Article and Find Full Text PDFNat Commun
January 2025
Laboratory of PhysioPharmacology, University of Antwerp, Antwerp, Belgium.
Heart failure is a common and deadly disease requiring new treatments. The neuregulin-1/ERBB4 pathway offers cardioprotective benefits, but using recombinant neuregulin-1 as therapy has limitations due to the need for intravenous delivery and lack of receptor specificity. We hypothesize that small-molecule activation of ERBB4 could protect against heart damage and fibrosis.
View Article and Find Full Text PDFInt J Cardiol
January 2025
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, United States of America. Electronic address:
Background: We hypothesized that patients with coarctation of aorta (COA) and obesity would have more advanced cardiovascular remodeling and impaired aerobic capacity compared to COA patients without obesity. The purpose of this study was to assess the relationship between obesity, cardiovascular remodeling, and aerobic capacity in adults with repaired COA.
Method: The study comprised of 3 groups: (1) Obese COA group (n=177) (COA patients with body mass index [BMI] >30 kg/m); (2) Non-obese COA group (n=572) (COA patients with BMI ≤30 kg/m); (3) Control group (n=59) (subjects without structural heart disease and BMI ≤30 kg/m).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!